• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国阿尔茨海默病和轻度认知障碍患者的血清结合珠蛋白:一项病例对照研究。

Serum haptoglobin in Chinese patients with Alzheimer's disease and mild cognitive impairment: A case-control study.

机构信息

Department of Neurology, Ruijin Hospital affiliated with the School of Medicine, Shanghai Jiao Tong University, 197 Ruijin No. 2 Road, Shanghai, 200025, China; School of Public Health, Shanghai Jiao Tong University, 227 Chong Qing Nan Road, Shanghai, 200025, China.

Department of Learning, Informatics, Management and Ethics, Karolinska Institute, Stockholm, 17177, Sweden.

出版信息

Brain Res Bull. 2018 Mar;137:301-305. doi: 10.1016/j.brainresbull.2018.01.005. Epub 2018 Jan 9.

DOI:10.1016/j.brainresbull.2018.01.005
PMID:29325993
Abstract

BACKGROUND

Serum level of Haptoglobin (Hp) maybe associated with Alzheimer's disease (AD) and mild cognitive impairment (MCI).

OBJECTIVE

To investigate associations between serum Hp and AD, as well as between Hp and MCI.

METHODS

Serum levels of Hp were measured and analyzed for 51 patients with AD, 139 patients with MCI and their healthy controls matched with sex and age. All study subjects were from a survey among residents aged 60 years and over in a community located in the southwest suburb of Shanghai.

RESULTS

Serum levels of Hp were observed significantly higher in AD and MCI cases than controls (both p < 0.0001). A significant positive correlation was found between Hp and Activities of Daily Living (ADL) score (r = 0.430, p = 0.007), as well as between Hp and Clinical Dementia Rating (CDR) score (r = 0.359, p = 0.027) in all AD patients. According to the receiver operating characteristic (ROC) curve analysis, the optimal cut-off point for Hp was found to be 67.50 μg/ml (sensitivity, 0.902; specificity, 0.745) in AD patients, and 44.76 μg/ml (sensitivity, 0.986; specificity, 0.403) in MCI patients.

CONCLUSION

Elevated serum levels of Hp were observed in AD and MCI patients than controls. In addition, Hp may correlate with the severity of AD.

摘要

背景

血清结合珠蛋白(Hp)水平可能与阿尔茨海默病(AD)和轻度认知障碍(MCI)有关。

目的

研究血清 Hp 与 AD 以及与 MCI 之间的关系。

方法

对 51 例 AD 患者、139 例 MCI 患者及其性别和年龄相匹配的健康对照者进行血清 Hp 水平测量和分析。所有研究对象均来自上海西南郊区某社区 60 岁及以上居民的一项调查。

结果

AD 和 MCI 患者的血清 Hp 水平明显高于对照组(均 p<0.0001)。在所有 AD 患者中,Hp 与日常生活活动能力(ADL)评分(r=0.430,p=0.007)以及与临床痴呆评定量表(CDR)评分(r=0.359,p=0.027)之间存在显著正相关。根据受试者工作特征(ROC)曲线分析,发现 Hp 的最佳截断值在 AD 患者中为 67.50μg/ml(灵敏度为 0.902,特异性为 0.745),在 MCI 患者中为 44.76μg/ml(灵敏度为 0.986,特异性为 0.403)。

结论

AD 和 MCI 患者的血清 Hp 水平高于对照组。此外,Hp 可能与 AD 的严重程度有关。

相似文献

1
Serum haptoglobin in Chinese patients with Alzheimer's disease and mild cognitive impairment: A case-control study.中国阿尔茨海默病和轻度认知障碍患者的血清结合珠蛋白:一项病例对照研究。
Brain Res Bull. 2018 Mar;137:301-305. doi: 10.1016/j.brainresbull.2018.01.005. Epub 2018 Jan 9.
2
Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.2 型糖尿病患者轻度认知障碍早期诊断的生物标志物:一项多中心、回顾性、巢式病例对照研究。
EBioMedicine. 2016 Feb 6;5:105-13. doi: 10.1016/j.ebiom.2016.02.014. eCollection 2016 Mar.
3
Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer's Disease and Mild Cognitive Impairment Patients.阿尔茨海默病和轻度认知障碍患者血清中Tau及磷酸化Tau181的测定
PLoS One. 2016 Jul 26;11(7):e0159099. doi: 10.1371/journal.pone.0159099. eCollection 2016.
4
Plasma Homocysteine and Serum Folate and Vitamin B Levels in Mild Cognitive Impairment and Alzheimer's Disease: A Case-Control Study.轻度认知障碍和阿尔茨海默病患者的血浆同型半胱氨酸、血清叶酸和维生素B水平:一项病例对照研究。
Nutrients. 2017 Jul 8;9(7):725. doi: 10.3390/nu9070725.
5
Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches.血浆谷氨酸水平检测轻度认知障碍和阿尔茨海默病:机器学习方法。
J Psychopharmacol. 2021 Mar;35(3):265-272. doi: 10.1177/0269881120972331. Epub 2021 Feb 15.
6
Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease.脑脊液中的血浆视黄醇结合蛋白和触珠蛋白前体等位基因1:从正常认知到轻度认知障碍再到阿尔茨海默病进展过程中的候选生物标志物。
Neurosci Lett. 2008 May 9;436(2):153-7. doi: 10.1016/j.neulet.2008.03.010. Epub 2008 Mar 18.
7
Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease.轻度认知障碍和阿尔茨海默病患者的血清维生素 D 水平。
Brain Behav. 2018 Feb 9;8(3):e00936. doi: 10.1002/brb3.936. eCollection 2018 Mar.
8
Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.体重指数降低与 MCI 和轻度痴呆患者的阿尔茨海默病病理的脑脊液标志物有关。
Exp Gerontol. 2017 Dec 15;100:45-53. doi: 10.1016/j.exger.2017.10.013. Epub 2017 Oct 17.
9
Serum tumour necrosis factor-α and interleukin-6 levels in Alzheimer's disease and mild cognitive impairment.阿尔茨海默病和轻度认知障碍患者血清肿瘤坏死因子-α及白细胞介素-6水平
Psychogeriatrics. 2017 Jul;17(4):224-230. doi: 10.1111/psyg.12218. Epub 2017 Jan 28.
10
T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.T1rho磁共振成像与脑脊液生物标志物在阿尔茨海默病诊断中的应用
Neuroimage Clin. 2015 Feb 26;7:598-604. doi: 10.1016/j.nicl.2015.02.016. eCollection 2015.

引用本文的文献

1
Protein profiling and assessment of amyloid beta levels in plasma in canine refractory epilepsy.犬难治性癫痫血浆中蛋白质谱分析及β-淀粉样蛋白水平评估
Front Vet Sci. 2023 Dec 21;10:1258244. doi: 10.3389/fvets.2023.1258244. eCollection 2023.
2
Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer's disease: findings based on urine proteomics and machine learning.基于尿液蛋白质组学和机器学习的轻度认知障碍和阿尔茨海默病新型诊断标志物的鉴定。
Alzheimers Res Ther. 2023 Nov 4;15(1):191. doi: 10.1186/s13195-023-01324-4.
3
Elucidating the Mechanisms of Sodium Benzoate in Alzheimer Disease: Insights from Quantitative Proteomics Analysis of Serum Samples.
苯甲酸钠在阿尔茨海默病中的作用机制研究:血清样本定量蛋白质组学分析的启示。
Int J Neuropsychopharmacol. 2023 Dec 18;26(12):856-866. doi: 10.1093/ijnp/pyad061.
4
Extracellular protein homeostasis in neurodegenerative diseases.神经退行性疾病中的细胞外蛋白动态平衡。
Nat Rev Neurol. 2023 Apr;19(4):235-245. doi: 10.1038/s41582-023-00786-2. Epub 2023 Feb 24.
5
Salivary inflammatory biomarkers are predictive of mild cognitive impairment and Alzheimer's disease in a feasibility study.在一项可行性研究中,唾液炎症生物标志物可预测轻度认知障碍和阿尔茨海默病。
Front Aging Neurosci. 2022 Nov 10;14:1019296. doi: 10.3389/fnagi.2022.1019296. eCollection 2022.
6
Phosphorylated Tau 181 Serum Levels Predict Alzheimer's Disease in the Preclinical Stage.磷酸化Tau 181血清水平可预测临床前期阿尔茨海默病。
Front Aging Neurosci. 2022 Jun 13;14:900773. doi: 10.3389/fnagi.2022.900773. eCollection 2022.
7
Identification of Potential Targets Linked to the Cardiovascular/Alzheimer's Axis through Bioinformatics Approaches.通过生物信息学方法识别与心血管/阿尔茨海默病轴相关的潜在靶点。
Biomedicines. 2022 Feb 6;10(2):389. doi: 10.3390/biomedicines10020389.
8
Potential Serum Biomarkers for Postoperative Neurocognitive Disorders Based on Proteomic Analysis of Cognitive-Related Brain Regions.基于认知相关脑区蛋白质组学分析的术后神经认知障碍潜在血清生物标志物
Front Aging Neurosci. 2021 Sep 29;13:741263. doi: 10.3389/fnagi.2021.741263. eCollection 2021.
9
Exosomal Aβ-Binding Proteins Identified by "In Silico" Analysis Represent Putative Blood-Derived Biomarker Candidates for Alzheimer´s Disease.通过“计算机分析”鉴定的外泌体 Aβ 结合蛋白代表阿尔茨海默病潜在的血源性生物标志物候选物。
Int J Mol Sci. 2021 Apr 11;22(8):3933. doi: 10.3390/ijms22083933.
10
Set-Based Rare Variant Expression Quantitative Trait Loci in Blood and Brain from Alzheimer Disease Study Participants.基于集合的罕见变异表达数量性状基因座在阿尔茨海默病研究参与者的血液和大脑中的研究。
Genes (Basel). 2021 Mar 15;12(3):419. doi: 10.3390/genes12030419.